Bio Pharma Dive
APRIL 8, 2021
Keytruda has become the first drug of its kind to succeed in the so-called adjuvant setting in renal cell carcinoma, continuing an industry-wide push to establish immunotherapy in earlier lines of cancer care.
pharmaphorum
APRIL 8, 2021
A digital tool used to treat attention-deficit hyperactivity disorder (ADHD) is being tested to see if it can help counter lingering, fuzzy thinking in COVID-19 survivors, a condition sometimes known as ‘brain fog’ An app called EndeavorRx – developed by PureTech Health-backed Akili Interactive – will be tested in two clinical trials to see if it can improve cognitive function in people who have recovered from COVID-19 but still show cognitive problems weeks or months later.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
APRIL 8, 2021
Baricitinib, an oral tablet already authorized to treat COVID-19, fell short of goal in a large Phase 3 study. But Lilly also reported treatment led to a substantial reduction in death.
Triage Cancer
APRIL 8, 2021
It's spring. We're starting to emerge from, well, a lot of things. Over the past year, I've heard just about every kind of organizing/decluttering/reordering response to our pandemic isolation and work-from-home shifts. Some folks, stuck in their spaces with less to do than usual and feeling claustrophobic, jumped on the decluttering bandwagon and cleared things out with a vengeance.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Bio Pharma Dive
APRIL 8, 2021
A deal with Bio-Thera Solutions hands Biogen rights to a late-stage copycat of Actemra, Roche's blockbuster treatment for inflammatory diseases.
BioSpace
APRIL 8, 2021
BioSpace takes a look at the annual compensation for the chief executive officers of vaccine developers.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Scienmag
APRIL 8, 2021
Pulp mill waste hits the road instead of the landfill Credit: UBCO Waste materials from the pulp and paper industry have long been seen as possible fillers for building products like cement, but for years these materials have ended up in the landfill. Now, researchers at UBC Okanagan are developing guidelines to use this waste […].
BioSpace
APRIL 8, 2021
Data on multiple oncology therapeutic programs are being unveiled ahead of the start of the annual American Association for Cancer Research meeting, which will be held virtually this year due to the ongoing COVID-19 pandemic.
Scienmag
APRIL 8, 2021
Credit: © Terence Strick The Mfd protein repairs bacterial DNA, but can also, to scientists’ surprise, promote mutation. Bacterial mutations can lead to antibiotic resistance. Understanding this second “role” of the Mfd protein opens up opportunities for combating antibiotic resistance, and also the resistance of tumours to anti-cancer drugs and therapies.
BioPharma Reporter
APRIL 8, 2021
Moderna today highlighted the publication of antibody persistence data out to six months following the second dose of its COVID-19 vaccine in The New England Journal of Medicine.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Scienmag
APRIL 8, 2021
By mashing up brains from various insect species, neuroscientists at the University of Arizona were able to count the neurons in individual brains, providing a more meaningful metric than traditional studies measuring brain size or weight. Credit: Wulfila Gronenberg Using a surprisingly simple technique, researchers in the University of Arizona Department of Neuroscience have succeeded […].
BioSpace
APRIL 8, 2021
While a failed ebola drug helped treat hospitalized COVID-19 patients, the common cold virus could become key in treating advanced unresectable cancers.
Scienmag
APRIL 8, 2021
BU environmental expert says the Nintendo racing game has important lessons for social and economic programs that could benefit the world’s developing regions Credit: Photo courtesy of The Brink staff Many Mario Kart enthusiasts are familiar with the rush of racing down Rainbow Road, barely squeaking around a corner, and catching a power-up from one […].
BioSpace
APRIL 8, 2021
Tidal Therapeutics, which does not even have a website, came out of LabCentral in Cambridge. It focuses on developing nanoparticles able to deliver messenger RNA (mRNA) that can reprogram immune cells.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
BioPharma Reporter
APRIL 8, 2021
Valneva will take its COVID-19 vaccine candidate into a Phase 3 clinical trial this month, following positive Phase 1/2 data for the inactivated, adjuvanted vaccine.
Scienmag
APRIL 8, 2021
Credit: Aira Burkhart/West Virginia University When you think of ways to treat opioid use disorder, you might think methadone clinics and Narcotics Anonymous meetings. You probably don’t imagine stretches and strengthening exercises. But Anne Swisher–professor at the West Virginia University School of Medicine–is working to address opioid misuse in an unconventional way: through physical therapy. […].
BioSpace
APRIL 8, 2021
The fear caused by COVID-19 provides an “in” for fraudsters to exploit thousands of Americans by posing as biotech companies.
Scienmag
APRIL 8, 2021
This full assembly may contain clues to ape and human divergence; certain immune, brain and heart disorders; and other biomedical questions Credit: Kendra Hoekzema The full assembly of human chromosome 8 is reported this week in Nature. While on the outside this chromosome looks typical, being neither short nor long or distinctive, its DNA content […].
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Outsourcing Pharma
APRIL 8, 2021
The collaboration will enable Charles River clients to access Valenceâs artificial intelligence platform in their pharmaceutical development projects.
Scienmag
APRIL 8, 2021
Credit: ©Matt Kapust Below the verdant surface and organic rich soil, life extends kilometers into Earth’s deep rocky crust. The continental deep subsurface is likely one of the largest reservoirs of bacteria and archaea on Earth, many forming biofilms – like a microbial coating of the rock surface. This microbial population survives without light or […].
Pharma Times
APRIL 8, 2021
Kesimpta is the first self-administered B-cell therapy for patients with relapsing forms of multiple sclerosis
BioSpace
APRIL 8, 2021
Bristol Myers Squibb announced topline data from the Phase III CheckMate -648 trial on Thursday, with positive results in esophageal cancer.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
pharmaphorum
APRIL 8, 2021
COVID-19 has been a trial-by-fire showing just how quickly drugs and vaccines can be developed under the right circumstances – but there is much to do to ensure this progress is not lost, said speakers at WIRED Health 2021, including the CEOs of BioNTech and BenevolentAI. . The 2021 WIRED Health conference took a broad view of the current pandemic situation, with speakers ranging from geneticists to intensive care doctors.
BioSpace
APRIL 8, 2021
Vaccine makers are working to create boosters or modify their existing vaccines to better respond to the variants.
pharmaphorum
APRIL 8, 2021
Gilead’s $21 billion purchase of Immunomedics and its potential blockbuster Trodelvy continues to pay off, as the drug has now been approved by the FDA for triple-negative breast cancer. . Trodelvy (sacituzumab govitecan) was granted accelerated approval by the FDA in April last year, and is now indicated for adults with triple-negative breast cancer who have received at least two previous therapies for metastatic disease.
BioSpace
APRIL 8, 2021
There continue to be studies and trials related to vaccines and drugs against COVID-19. Here’s a look.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
APRIL 8, 2021
Newly clarified reactions point to novel applications for a long-studied lithium-rich battery material Credit: Berkeley Lab An international team working at the U.S. Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) used a unique X-ray instrument to learn new things about lithium-rich battery materials that have been the subject of much study for their […].
BioSpace
APRIL 8, 2021
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Scienmag
APRIL 8, 2021
Credit: UT Southwestern Medical Center DALLAS – April 8, 2021 – New research has uncovered a surprising role for so-called “jumping” genes that are a source of genetic mutations responsible for a number of human diseases. In the new study from Children’s Medical Center Research Institute at UT Southwestern (CRI), scientists made the unexpected discovery […].
Outsourcing Pharma
APRIL 8, 2021
The AWARE for All virtual event series aims to educate and engage the public as important partners in clinical trials and development of new treatments.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
294 
Let's personalize your content